A citation-based method for searching scientific literature

Rama Hritani, Aliza Hussain, Anum Saeed, Anandita Agarwala. Future Cardiol 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Report from the 5th cardiovascular outcome trial (CVOT) summit.
Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo Jl Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello. Cardiovasc Diabetol 2020
14
50

Canagliflozin: metabolic, cardiovascular and renal protection.
Vivencio Barrios, Carlos Escobar. Future Cardiol 2021
2
50




Metformin in the era of new antidiabetics.
Ez Alddin Rajjoub Al-Mahdi, Vivencio Barrios, Jose L Zamorano. Future Cardiol 2021
1
100


Canakinumab for secondary prevention of coronary artery disease.
Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo. Future Cardiol 2021
2
50

Cardiovascular outcome trials in Type 2 diabetes: food for thought.
Jadin J Chahade, Ryekjang Kim, John R Ussher. Future Cardiol 2021
1
100


Cardiovascular disease prevention and therapy in women with Type 2 diabetes.
Camilla Cocchi, Francesca Coppi, Alberto Farinetti, Anna Vittoria Mattioli. Future Cardiol 2021
3
50

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.
William T Cefalu, Sanjay Kaul, Hertzel C Gerstein, Rury R Holman, Bernard Zinman, Jay S Skyler, Jennifer B Green, John B Buse, Silvio E Inzucchi, Lawrence A Leiter,[...]. Diabetes Care 2018
228
50

Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
Johny Nicolas, Victor Razuk, Gennaro Giustino, Roxana Mehran. Future Cardiol 2021
1
100

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men.
N Faghihnia, L M Mangravite, S Chiu, N Bergeron, R M Krauss. Eur J Clin Nutr 2012
20
50

VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.
Gaia Botteri, Marta Montori, Anna Gumà, Javier Pizarro, Lídia Cedó, Joan Carles Escolà-Gil, Diana Li, Emma Barroso, Xavier Palomer, Alison B Kohan,[...]. Diabetologia 2017
16
50





Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
J Auwerx, K Schoonjans, J C Fruchart, B Staels. J Atheroscler Thromb 1996
78
50

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.
Shizuya Yamashita, Hidenori Arai, Koutaro Yokote, Eiichi Araki, Mitsunori Matsushita, Toshiaki Nojima, Hideki Suganami, Shun Ishibashi. Int J Mol Sci 2019
17
50

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity.
Mengdie Luo, Aiying Liu, Shuai Wang, Tianle Wang, Die Hu, Sha Wu, Daoquan Peng. Sci Rep 2017
34
50

Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes.
Sharon Li Ting Pek, Chee Fang Sum, Lee Ying Yeoh, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim, Subramaniam Tavintharan. Metabolism 2017
7
50

Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
Jan Oscarsson, Kristina Önnerhag, Ulf Risérus, Mattias Sundén, Lars Johansson, Per-Anders Jansson, Linda Moris, Peter M Nilsson, Jan W Eriksson, Lars Lind. J Clin Lipidol 2018
33
50


The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Jan Borén, Chris J Packard, Marja-Riitta Taskinen. Front Endocrinol (Lausanne) 2020
24
50

Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials.
Amirhossein Sahebkar, Luis E Simental-Mendía, Dimitri P Mikhailidis, Matteo Pirro, Maciej Banach, Cesare R Sirtori, Massimiliano Ruscica, Željko Reiner. J Clin Lipidol 2018
14
50

Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction.
Oliviero Olivieri, Nicola Martinelli, Marco Sandri, Antonella Bassi, Patrizia Guarini, Elisabetta Trabetti, Francesca Pizzolo, Domenico Girelli, Simonetta Friso, Pier Franco Pignatti,[...]. Clin Chem 2005
44
50



Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.
Karin Åvall, Yusuf Ali, Ingo B Leibiger, Barbara Leibiger, Tilo Moede, Meike Paschen, Andrea Dicker, Elisabetta Daré, Martin Köhler, Erwin Ilegems,[...]. Proc Natl Acad Sci U S A 2015
52
50


Apoprotein C-III: A review of its clinical implications.
Jing-Lu Jin, Yuan-Lin Guo, Jian-Jun Li. Clin Chim Acta 2016
12
50

Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.
Amirhossein Sahebkar, Luis E Simental-Mendía, Niki Katsiki, Željko Reiner, Maciej Banach, Matteo Pirro, Stephen L Atkin. BMJ Open 2019
10
50

Reducing residual cardiovascular risk with novel therapies.
Michael H Davidson. Curr Opin Lipidol 2020
2
50


Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
Oliviero Olivieri, Manuel Cappellari, Gianni Turcato, Bruno Bonetti, Domenico Girelli, Francesca Pizzolo, Simonetta Friso, Antonella Bassi, Annalisa Castagna, Nicola Martinelli. Stroke 2020
4
50

Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation.
Stephen Zewinger, Jochen Reiser, Vera Jankowski, Dalia Alansary, Eunsil Hahm, Sarah Triem, Mira Klug, Stefan J Schunk, David Schmit, Rafael Kramann,[...]. Nat Immunol 2020
74
50


Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.
Mark J Graham, Richard G Lee, Thomas A Bell, Wuxia Fu, Adam E Mullick, Veronica J Alexander, Walter Singleton, Nick Viney, Richard Geary, John Su,[...]. Circ Res 2013
243
50


Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes.
Andres Digenio, Richard L Dunbar, Veronica J Alexander, Marcus Hompesch, Linda Morrow, Richard G Lee, Mark J Graham, Steven G Hughes, Rosie Yu, Walter Singleton,[...]. Diabetes Care 2016
91
50

Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
Nicola Martinelli, Marcello Baroni, Annalisa Castagna, Barbara Lunghi, Filippo Stefanoni, Federica Tosi, Jacopo Croce, Silvia Udali, Barry Woodhams, Domenico Girelli,[...]. Thromb Haemost 2019
11
50



Key differences between apoC-III regulation and expression in intestine and liver.
Gabrielle West, Cayla Rodia, Diana Li, Zania Johnson, Hongli Dong, Alison B Kohan. Biochem Biophys Res Commun 2017
6
50

Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
Hui-Young Lee, Andreas L Birkenfeld, Francois R Jornayvaz, Michael J Jurczak, Shoichi Kanda, Violeta Popov, David W Frederick, Dongyan Zhang, Blas Guigni, Kalyani G Bharadwaj,[...]. Hepatology 2011
94
50


Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.
Anna Helgadottir, Solveig Gretarsdottir, Gudmar Thorleifsson, Eirikur Hjartarson, Asgeir Sigurdsson, Audur Magnusdottir, Aslaug Jonasdottir, Helgi Kristjansson, Patrick Sulem, Asmundur Oddsson,[...]. Nat Genet 2016
150
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.